Prognostic markers are often identified through extensive research involving the analysis of patient data and biological samples. Techniques such as immunohistochemistry (IHC), polymerase chain reaction (PCR), and next-generation sequencing (NGS) are commonly used to discover and validate these markers. Clinical trials and cohort studies also play a significant role in establishing the relevance and reliability of these markers.
